Compare EVT & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | EVT | HTFL |
|---|---|---|
| Founded | N/A | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.2B |
| IPO Year | 2003 | 2025 |
| Metric | EVT | HTFL |
|---|---|---|
| Price | $25.11 | $46.31 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $65.00 |
| AVG Volume (30 Days) | 110.2K | ★ 1.6M |
| Earning Date | 01-01-0001 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 82.37 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $176,034,000.00 |
| Revenue This Year | N/A | $49.74 |
| Revenue Next Year | N/A | $24.54 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 39.92 |
| 52 Week Low | $23.45 | $20.13 |
| 52 Week High | $29.65 | $60.66 |
| Indicator | EVT | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 26.13 | 39.82 |
| Support Level | $24.56 | $22.47 |
| Resistance Level | $26.55 | $52.38 |
| Average True Range (ATR) | 0.60 | 3.68 |
| MACD | -0.18 | -1.47 |
| Stochastic Oscillator | 2.01 | 13.99 |
EATON VANCE TAX ADVANTAGED DIVIDEND INCOME FUND is a diversified, closed-end management investment company. Its objective is to provide a high level of after-tax total return consisting mainly of tax-advantaged dividend income and capital appreciation. The fund pursues its objective by investing in dividend-paying common and preferred stocks. Its portfolio of investments consists of electric utilities, energy equipment and services, food products, health care providers and services, internet software and services, and other areas.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.